A SYSTEMATIC REVIEW OF LONG COVID MANIFESTATIONS AND THEIR IMPACT ON QUALITY OF LIFE (2020-2024)

Main Article Content

Dr Abhishek Kumar Aditya
Dr Kamal.Kant
Dr Nitin Chauhan
Dr. Manju Pandey

Keywords

COVID, PASC, Fatigue, Cognitive, Dysfunction, Rehabilitation, PTSD, Healthcare, Systems, Anxiety, Depression, Prevalence

Abstract

Long COVID or post-acute sequelae of SARS-CoV-2 infection (PASC) has become a serious issue as long as millions of people worldwide are being impacted by this condition. The article aims to discuss long COVID symptoms and their consequences for patients in terms of subjective well-being prevalence on the basis of material from 2020 to 2024. In order to present the information gathered from peer-reviewed journals, we aim at presenting the long-term health impact, social and health-related costs, and research agenda.

Abstract 81 | pdf Downloads 58

References

1. Davis, H.E., Assaf, G.S., McCorkell, L., Wei, H., Low, R.J., Re'em, Y., Redfield, S., Austin, J.P. and Akrami, A., 2021. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine, 38, p.101019.
2. Doykov, I., Hällqvist, J., Gilmour, K.C., Grandjean, L., Mills, K. and Heywood, W.E., 2021. The long tail of COVID-19—The detection of persistent SARS-CoV-2 RNA in monocytes up to 15 months post-infection. Frontiers in Immunology, 12, p.746021.
3. Evans, R.A., McAuley, H., Harrison, E.M., Shikotra, A., Singapuri, A., Sereno, M., Elneima, O., Docherty, A.B., Lone, N.I., Leavy, O.C. and Daines, L., 2021. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. The Lancet Respiratory Medicine, 9(11), pp.1275-1287.
4. Fernández-de-las-Peñas, C., Palacios-Ceña, D., Gómez-Mayordomo, V., Cuadrado, M.L., Florencio, L.L., Andrés, E.G., Hernández-Barrera, V. and Arendt-Nielsen, L., 2021. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. International Journal of Environmental Research and Public Health, 18(5), p.2621.
5. Groff, D., Sun, A., Ssentongo, A.E., Ba, D.M., Parsons, N., Poudel, G.R., Lekoubou, A., Oh, J.S., Ericson, J.E., Ssentongo, P. and Chinchilli, V.M., 2021. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Network Open, 4(10), p.e2128568.
6. Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X. and Luo, J., 2021. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet, 397(10270), pp.220-232.
7. Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M.V., McGroder, C., Stevens, J.S., Cook, J.R., Nordvig, A.S., Shalev, D., Sehrawat, T.S. and Ahluwalia, N., 2021. Post-acute COVID-19 syndrome. Nature Medicine, 27(4), pp.601-615.
8. Raveendran, A.V., Jayadevan, R. and Sashidharan, S., 2021. Long COVID: an overview. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15(3), pp.869-875.
9. Sudre, C.H., Murray, B., Varsavsky, T., Graham, M.S., Penfold, R.S., Bowyer, R.C., Pujol, J.C., Klaser, K., Antonelli, M., Canas, L.S. and Molteni, E., 2021. Attributes and predictors of long COVID. Nature Medicine, 27(4), pp.626-631.
10. Taquet, M., Geddes, J.R., Husain, M., Luciano, S. and Harrison, P.J., 2021. 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry, 8(5), pp.416-427.
11. Tran, V.T., Riveros, C., Clepier, B., Desvarieux, D. and Ravaud, P., 2022. Development and validation of the long COVID symptom and impact tools: a set of patient-reported instruments constructed from patients' lived experience. Clinical Infectious Diseases, 74(5), pp.755-763.
12. Ziauddeen, N., Gurdasani, D., O’Hara, M.E., Hastie, C., Roderick, P., Yao, G. and Alwan, N.A., 2022. Characteristics and impact of long COVID: findings from an online survey. PLOS ONE, 17(3), p.e0264330.